The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

HCM HUTCHISON CHINA MEDITECH LIMITED ORD USD1




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
07:00 20-Feb-2017 HCM Start of Phase II Savolitinib PSC trial in China RNS -1.31% Down
07:07 14-Feb-2017 HCM Initiates Phase I of Novel FGFR Inhibitor HMPL-453 RNS +0.75% Up
07:00 14-Feb-2017 HCM Savolitinib PRCC Results Presentation at ASCO GU RNS +0.75% Up
07:00 06-Feb-2017 HCM Chi-Med to Announce 2016 Final Results RNS -2.55% Down
07:00 01-Feb-2017 HCM Change of Directors RNS -1.50% Down
10:48 16-Jan-2017 HCM Change of Directors RNS -1.25% Down
07:30 16-Jan-2017 HCM Fruquintinib Phase I/II Clinical Data at ASCO GI RNS -1.25% Down
07:29 16-Jan-2017 HCM Sulfatinib Phase II Study in 2nd Line BTC in China RNS -1.25% Down
07:16 16-Jan-2017 HCM Fruquintinib Combination Study in 1st-Line NSCLC RNS -1.25% Down
07:00 10-Jan-2017 HCM Chi-Med Initiates HMPL-523 Clinical Trials RNS -2.43% Down
09:11 30-Dec-2016 HCM Total Voting Rights RNS +0.02% Up
07:40 29-Dec-2016 HCM Blocklisting Six Monthly Return RNS -0.02% Down
07:18 20-Dec-2016 HCM Director's Share Dealing RNS +0.11% Up
07:14 14-Dec-2016 HCM Director's Share Dealing RNS +1.40% Up
07:00 06-Dec-2016 HCM HMPL-523 Pre-clinical Data Presented at ASH RNS +3.19% Up
07:51 30-Nov-2016 HCM Exercise of Share Options RNS +15.30% Up
07:48 30-Nov-2016 HCM Total Voting Rights RNS +15.30% Up
07:34 23-Nov-2016 HCM Director's Share Dealing RNS +3.31% Up
07:30 23-Nov-2016 HCM Chi-Med to Present Data at the 17th WCLC RNS +3.31% Up
09:06 14-Nov-2016 HCM Chi-Med Presents Ph I Clinical Data for HMPL-523 RNS +0.77% Up

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address Ugland House, George Town, Grand Cayman, P.O. BOX 309, Cayman Islands
Company website -
Market cap(in millions)* £ 1,274.95
Listing/Admission to trading 19 May 2006
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
24-Feb-17
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register GB
Segment AIMI
MiFID Status MTF
Exchange market size 750
SEDOL B11Y2X4
ISIN number KYG4672N1016



HUTCHISON CHINA share news analysis (HCM)